Edition:
India

ARMO Biosciences Inc (ARMO.OQ)

ARMO.OQ on NASDAQ Stock Exchange Global Select Market

28.26USD
20 Apr 2018
Change (% chg)

-- (--)
Prev Close
$28.26
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
--
52-wk High
$57.00
52-wk Low
$25.14

Chart for

About

ARMO Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on developing immunotherapies for the treatment of cancer, cardiovascular disease, fibrosis and inflammation. The Company's platform molecule AM0010 is a pegylated form of recombinant human IL-10, which has immune stimulating effects that... (more)

Overall

No Ratios Available.

Financials

BRIEF-Armo Biosciences Enrolls Patient In The Cypress 2 Trial Evaluating AM0010

* ARMO BIOSCIENCES ENROLLS FIRST PATIENT IN THE CYPRESS 2 TRIAL EVALUATING AM0010 IN NON-SMALL CELL LUNG CANCER Source text for Eikon: Further company coverage:

29 Mar 2018

BRIEF-Armo Biosciences Announces Positive Outcome Of First Interim Analysis In Sequoia Phase 3 Pancreatic Cancer Study

* ARMO BIOSCIENCES ANNOUNCES POSITIVE OUTCOME OF FIRST INTERIM ANALYSIS IN SEQUOIA PHASE 3 PANCREATIC CANCER STUDY

26 Mar 2018

BRIEF-ARMO Biosciences Sees IPO Of Up To 6.7 Mln Shares Of Common Stock, Estimated IPO Price Between $14 And $16/Shr

* ARMO BIOSCIENCES INC SEES IPO OF UP TO 6.7 MILLION SHARES OF COMMON STOCK AND ESTIMATED IPO PRICE BETWEEN $14.00 AND $16.00 PER SHARE - SEC FILING

16 Jan 2018

Earnings vs. Estimates